Donald Small Jr., who has Parkinson's disease, will spend at least a couple of years in a prison for fatally stabbing his ...

Gene Mack, Gain Therapeutics CEO, provides a look into the future of the company and the use of physics-based artificial ...

The glucagon-like peptide-1 receptor agonist exenatide does not yield improvement in measures of Parkinson disease severity.